Literature DB >> 17376003

Photochemical scar ablation in chronically contused spinal cord of rat.

Shuxin Zhang1, Bridget Kluge, Fengfa Huang, Tuija Nordstrom, Suzanne Doolen, Mica Gross, Patrick Sarmiere, Eric G Holmberg.   

Abstract

Glial scar represents a physical and molecular barrier to axonal regeneration and has become an important target for regeneration research in chronic spinal cord injury. Although many methods have been proven useful for the prevention of scar formation in an acute injury model, to date no effective method has been described to remove an existing glial scar in a chronic injury. The chronic lesion possesses an irregular shaped scar that lines the entire perimeter of the cavity. In the present study, we used rose bengal, a molecule commonly used for biological staining, injected into the cavity at the injury site of Long-Evans rat spinal cord (5 weeks after 25-mm contusion injury). Visible light was used to illuminate the injury site. Histological observation illustrates that at least partial glial scar tissue is ablated by rose bengal/illumination. The lack of glial fibrillary acidic protein (GFAP) immunoreactivity at the glial scar coupled with the reduction of GFAP density surrounding spared tissue suggests that this photochemical scar ablation preferentially kills astrocytes at the scar tissue but also reacts, to a lesser degree, in the spared tissue. There is an observed reduction of Basso, Beattie, and Bresnahan (BBB) scale scores after scar ablation, but it is not statistically significant from stabilized behavioral scoring prior to the scar ablation treatment. Our findings indicate that the rose bengal/illumination is feasible for ablation of the glial scar which surrounds an irregular lesion cavity in shape. The scar ablation might provide a permissive environment for the regenerating axons when enriched by cellular or drug therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376003     DOI: 10.1089/neu.2006.0065

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

Review 1.  Scar-modulating treatments for central nervous system injury.

Authors:  Dingding Shen; Xiaodong Wang; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

2.  Safety and Efficacy of Rose Bengal Derivatives for Glial Scar Ablation in Chronic Spinal Cord Injury.

Authors:  Nandadevi Patil; Vincent Truong; Mackenzie H Holmberg; Nicolas S Lavoie; Mark R McCoy; James R Dutton; Eric G Holmberg; Ann M Parr
Journal:  J Neurotrauma       Date:  2018-04-19       Impact factor: 5.269

Review 3.  The glial scar in spinal cord injury and repair.

Authors:  Yi-Min Yuan; Cheng He
Journal:  Neurosci Bull       Date:  2013-07-16       Impact factor: 5.203

4.  Modulation of musculoskeletal hyperalgesia by brown adipose tissue activity in mice.

Authors:  Elizabeth M Goudie-DeAngelis; Ramy E Abdelhamid; Myra G Nunez; Casey L Kissel; Katalin J Kovács; Philip S Portoghese; Alice A Larson
Journal:  Pain       Date:  2016-11       Impact factor: 7.926

5.  Spinal cord injury: From inflammation to glial scar.

Authors:  Manoel Baldoino Leal-Filho
Journal:  Surg Neurol Int       Date:  2011-08-13

6.  Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury.

Authors:  Marc A DePaul; Ching-Yi Lin; Jerry Silver; Yu-Shang Lee
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

7.  Immunization with neural derived peptides plus scar removal induces a permissive microenvironment, and improves locomotor recovery after chronic spinal cord injury.

Authors:  Roxana Rodríguez-Barrera; Adrián Flores-Romero; Ana María Fernández-Presas; Elisa García-Vences; Raúl Silva-García; Mina Konigsberg; Liliana Blancas-Espinoza; Vinnitsa Buzoianu-Anguiano; Karla Soria-Zavala; Paola Suárez-Meade; Antonio Ibarra
Journal:  BMC Neurosci       Date:  2017-01-05       Impact factor: 3.288

8.  Role of endogenous Schwann cells in tissue repair after spinal cord injury.

Authors:  Shu-Xin Zhang; Fengfa Huang; Mary Gates; Eric G Holmberg
Journal:  Neural Regen Res       Date:  2013-01-15       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.